REGENERIX Trademark

Trademark Overview


On Friday, May 6, 2016, a trademark application was filed for REGENERIX with the United States Patent and Trademark Office. The USPTO has given the REGENERIX trademark a serial number of 87028441. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, March 24, 2017. This trademark is owned by Fiji Medical Consulting Group, LLC. The REGENERIX trademark is filed in the Pharmaceutical Products category with the following description:

Stem cells for medical purposes
regenerix

General Information


Serial Number87028441
Word MarkREGENERIX
Filing DateFriday, May 6, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, March 24, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesStem cells for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFiji Medical Consulting Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77080

Trademark Events


Event DateEvent Description
Friday, October 27, 2017UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, March 24, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, March 24, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 22, 2016NON-FINAL ACTION E-MAILED
Monday, August 22, 2016NON-FINAL ACTION WRITTEN
Monday, August 22, 2016ASSIGNED TO EXAMINER
Wednesday, May 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 10, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords


regenerix purposes medical cells stem